Global Preclinical Imaging Market overview:
Preclinical imaging refers to non-invasive imaging techniques used in the preclinical research studies for drug discovery, translational research, and development of therapeutic compounds in small animals. It provides structural and functional information about biological processes at the molecular and cellular level. Some commonly used preclinical imaging modalities include optical imaging, ultrasound imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), photoacoustic imaging, and computed tomography (CT). Preclinical imaging techniques enable researchers to monitor disease progression or treatment response in living subjects over time, reducing the number of laboratory animals needed.

The Global Preclinical Imaging Market is estimated to be valued at US$ 4.25 BN in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031.

Key Takeaways:
Key players operating in the Global Preclinical Imaging are Bruker Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics Inc. (Fujifilm), Inc., Mediso Ltd., Agilent Technologies, MILabs B.V., MR Solutions, and Molecubes.

The increasing Research and Development expenditure in pharmaceutical and biotechnology industries is driving the Preclinical Imaging Market Demand techniques for drug discovery and development. Moreover, advancement in imaging modalities such as high-resolution micro-MRI and micro-CT, and multimodal imaging systems is fueling the market growth. Major players are focusing on geographical expansion plans across emerging markets to leverage market opportunities.

Get More Insights on Preclinical Imaging Market